Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · IEX Real-Time Price · USD

6.22

-0.30 (-4.60%)

At close: Jul 2, 2024, 4:00 PM

6.39

+0.17 (2.73%)

After-hours: Jul 2, 2024, 7:31 PM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2006
Net Income	-1,002.24	175.07	528.45	106.18	21.51	Upgrade
Depreciation & Amortization	1.58	1.42	1.52	3.56	5.58	Upgrade
Share-Based Compensation	32.01	27.05	22.28	31.18	31.28	Upgrade
Other Operating Activities	1,152	70.23	-290.36	27.92	-47.64	Upgrade
Operating Cash Flow	183.43	273.76	261.9	168.84	10.73	Upgrade
Operating Cash Flow Growth	-33.00%	4.53%	55.12%	1474.23%	-	Upgrade
Capital Expenditures	-0.27	-0.14	-0.27	-1.84	-6.92	Upgrade
Acquisitions	-1,026.05	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-4.22	Upgrade
Investing Cash Flow	-1,026.32	-0.14	-0.27	-1.84	-11.14	Upgrade
Share Issuance / Repurchase	6.36	-116.85	-4.55	18.55	13.6	Upgrade
Debt Issued / Paid	297.11	-120.7	0	0	19.43	Upgrade
Other Financing Activities	-26.31	-	-	-	-34.21	Upgrade
Financing Cash Flow	277.16	-237.55	-4.55	18.55	-1.19	Upgrade
Exchange Rate Effect	-0.05	0	0	0	0	Upgrade
Net Cash Flow	-565.78	36.07	257.08	185.54	-1.6	Upgrade
Free Cash Flow	183.15	273.63	261.63	166.99	3.8	Upgrade
Free Cash Flow Growth	-33.06%	4.59%	56.67%	4289.96%	-	Upgrade
Free Cash Flow Margin	41.37%	66.64%	63.23%	42.87%	0.89%	Upgrade
Free Cash Flow Per Share	1.18	1.77	1.61	1.05	0.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).